China rapidly catching up with US in biotech

China is rapidly catching up with the US in biotech capabilities, leading in manufacturing and clinical development while the US maintains an edge in talent and market translation. The US has responded with measures like restricting federal dealings with foreign biotech firms and accelerating drug research to restore leadership in clinical trials.